Amgen
AMGN
Delayed Nasdaq - 11/17 10:00:00 pm
170USD
-0.45%

Back on key levels based on weekly price data

Envoyer par e-mail
Anas Lozach
 

Strategy published on : 11/10/2017 | 14:31

long trade
Live

Entry price : 173.15$
Target : 192$
Stop-loss : 164.9$
Potential : 10.89%

Amgen shares are closing near attractive entry levels for a medium term horizon. Investors could regard the decline over the past weeks as a buying opportunity.
Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


Strengths

● The close medium term support offers good timing for purchasing the stock.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Historically, the company has been releasing figures that are above expectations.

● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 167.29 USD


Weaknesses

● According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's "enterprise value to sales" ratio is among the highest in the world.

Zonebourse.com 2017
Envoyer par e-mail